{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
NCT03663088: Not Applicable Interventional Terminated Idiopathic Scoliosis
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03390296: Phase 1/Phase 2 Interventional Completed Recurrent Acute Myeloid Leukemia
(2017)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04612530: Phase 1 Interventional Recruiting Pancreatic Cancer
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:sacituzumab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:lutikizumab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04475692: Not Applicable Interventional Completed Stroke
(2021)
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
INN:zastumotide [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
NCT01686776: Phase 3 Interventional Completed Healthy
(2012)
Source URL:
Class:
PROTEIN
